The University of Southampton
University of Southampton Institutional Repository

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

Carr, A.J., Thompson, P.W. and Cooper, C. (2006) Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey Osteoporosis International, 17, (11), pp. 1638-1644. (doi:10.1007/s00198-006-0166-2).

Record type: Article


OBJECTIVE: To determine the factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis.
DESIGN: Cross-sectional survey.
SETTING: National survey in the UK.
PARTICIPANTS: Participants were recruited through the National Osteoporosis Society and advertisements in the press and on the radio and included 533 women over age 50 with osteoporosis who were currently taking or had taken bisphosphonate therapy within the previous 12 months.
MAIN OUTCOME MEASURES: Self-reported factors influencing adherence and persistence to bisphosphonate therapy in osteoporosis: fracture history, pain, practical difficulties taking medication (frequency of dosing, dealing with comedications, impact on daily routine), perceptions of therapy, and concerns about bisphosphonate therapy.
RESULTS: Adherence to bisphosphonate therapy was 48% and was associated with previous fracture [odds ratio (OR) 1.62, 95% confidence interval (CI) 1.14-3.02], concerns about medication (OR 1.49, 95% CI 1.01-2.20), and less dissatisfaction with medication (OR 0.65, 95% CI 0.44-0.97). Nonpersistence was associated with dissatisfaction with medication (hazard ratio (HR) 1.83, 95% CI 1.38-2.43), side effects (HR 3.69, 95% CI 2.74-4.97), and concerns about bisphosphonate therapy (HR 2.21, 95% CI 1.48-3.30). For both daily (HR 1.53, 95% CI 1.1-2.33) and weekly bisphosphonates (HR 1.90, 95% CI 1.17-3.07), practical difficulties taking bisphosphonate medication-in particular, too frequent dosing-were associated with nonpersistence.
CONCLUSIONS: Self-reported nonadherence to daily and weekly bisphosphonates is independent of the decision to stop taking treatment (nonpersistence). Nonpersistence is associated with side effects and other factors that could be modified in clinical practice through education, information, and concordant partnerships.

Full text not available from this repository.

More information

Published date: 2006
Keywords: societies, education, women, pain, bone, therapy, osteoporosis


Local EPrints ID: 60975
ISSN: 0937-941X
PURE UUID: 74cf4346-fcd9-404f-b33e-e047cf143526
ORCID for C. Cooper: ORCID iD

Catalogue record

Date deposited: 09 Sep 2008
Last modified: 17 Jul 2017 14:22

Export record



Author: A.J. Carr
Author: P.W. Thompson
Author: C. Cooper ORCID iD

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.